Simon Bond is a Group Leader in the Molecular Metabolism and Ageing laboratory, dedicated to improving the lives of individuals affected by mitochondrial diseases, cardiovascular diseases, and obesity. His groundbreaking work has played a crucial role in uncovering novel mechanisms that drive these conditions, with the ultimate goal of developing innovative therapeutic treatments.

Dr Bond obtained his BSc (Honours) and PhD in Molecular Biology from Deakin University's Metabolic Research Unit, where he demonstrated that acetylation regulates the activity of metabolic enzymes, a process found to be altered in type 2 diabetes and obesity. Following his PhD, Dr Bond joined the Baker Heart and Diabetes Institute, where his ongoing research aims to improve the treatment and diagnosis of complications associated with obesity, cardiometabolic disorders, and mitochondrial diseases. In particular, his research focuses on uncovering the molecular mechanisms driving these conditions by investigating mitochondrial and extracellular vesicle biology in metabolic tissues to identify new therapeutic and diagnostic targets.

Dr Bond has received ~$2M in competitive research funding from bodies including the NHMRC, CASS Foundation, MUNZ and the Heart Foundation. He co-manages the Baker Institute’s Mouse Metabolic Phenotyping Facility (MMPF) and Bioenergetics Core. In addition to his position at the Baker Institute, Dr Bond holds honorary Senior Research Fellow appointments at Monash University and the University of Melbourne.